Navigation Links
TriMix for Travel Now Available at KRS Global Biotechnology
Date:7/9/2013

BOCA RATON, Fla., July 9, 2013 /PRNewswire/ -- TriMix Laboratories today announced KRS Global Biotechnology is adding TriMix for Travel™ to its existing line of urological products.  TriMix for Travel™ is a non-refrigerated alternative for the erectile dysfunction (ED) treatment known as trimix for injection or just trimix.

(Photo:  http://photos.prnewswire.com/prnh/20130709/PH44051)

Trimix for injection is a liquid form of medicine that requires refrigeration.  Active patients find this cumbersome and inconvenient because they need to carry their medicine in ice packs whenever leaving home such as on vacation or nights on the town. 

This new formulation does not require refrigeration.  KRS is now accepting prescriptions for TriMix for Travel™.  Patients can mail their prescriptions to KRS or have their doctors use this form (http://trimixgel.com/trimixtravel/pdf/Trimix-for-Travel-Order-Form.pdf) to phone in the prescriptions at 888-368-1990 or fax them to 888-363-7266.

Wayne Krebs from KRS Marketing says, "Our patients have been asking for something like this for a long time. With TriMix for Travel, NO MORE ICE PACKS."  

Anyone interested in learning more about TriMix for Travel™ can visit www.TriMixforTravel.com.

TriMix Laboratories, LLC develops innovative products toward the clinical advancement of Urology.  KRS Global Biotechnology INC is a full service compounding pharmacy offering choices for urological patients and urology practices.  New products include a new non-refrigerated trimix called TriMix for Travel™, the original TriMix-gel® and custom formulations of trimix for injection, Bi-mix and Quad mix.

Contact:
T.J. Harkins
800-572-3330
Email

The information contained herein is general in nature and is intended for use only as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the products shown, nor is the information intended as medical advice or diagnosis for individual health problems. TriMix for Travel™ and TriMix-gel® have not been evaluated by the Food and Drug Administration ("FDA"). TriMix for Travel™ and TriMix-gel® are not made under GMP requirements. They are compounded in a licensed compounding pharmacy for the use of an individual patient who has been prescribed TriMix for Travel™ and TriMix-gel® by a licensed physician. It is not intended for making an evaluation as to the risks and benefits. Before taking any action, consult your Doctor.

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE TriMix Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Marshall study shows nanoparticles used as additives in diesel fuels can travel from lungs to liver
2. Engineer-turned-librarian awarded travel stipend by SPIE Digital Library
3. Immunology 2013™ Travel Grants Available from R&D Systems
4. Physicist Louis Del Monte Uses the Existence Equation Conjecture to Address “Is Time Travel Possible?”
5. R&D Systems is Offering Travel Grants to Attend the 15th International Congress of Immunology
6. Seahorse Bioscience Announces AACR Travel Award Recipients
7. Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post
8. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
9. SPIE Leaders Commend OMB Support for Travel to Scientific Conferences, Say Funding is Also Needed
10. Wolters Kluwer Research Now Available via Bloomberg Tradebook
11. Free Job Training: 55 Grants Available to Retrain Workers for Biofuels Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Eli Lilly and ... 2 data evaluating galcanezumab for the prevention of migraine ... which will take place April 22-28, 2017, in ... present four abstracts at AAN, including safety and patient ... factors associated with a reduction in monthly migraine headache ...
(Date:4/20/2017)... Woburn, MA (PRWEB) , ... April 20, 2017 ... ... high brightness light sources for advanced technology applications, announced today that Chief Executive ... Board (NAAB). , SEMI is the global industry association connecting the ...
(Date:4/20/2017)... 2017 For today, Stock-Callers.com redirects investors, ... development and clinical research aimed at treating diseases and medical ... Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), ... can access our complimentary research reports on these stocks now ... http://stock-callers.com/registration ...
(Date:4/19/2017)... ... 19, 2017 , ... Nobilis Therapeutics Announces Completion of Landmark NBTX-001 ... Data in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis Therapeutics, Inc. ... assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of Panic Disorder. ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
Breaking Biology News(10 mins):